Ubs Oconnor LLC Bicycle Therapeutics PLC Call Options Transaction History

Ubs Oconnor LLC

  • $1.46 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.58 - $27.24 $391,599 - $544,800
20,000 New
20,000 $453,000
Q1 2024

May 15, 2024
SELL
$16.75 - $26.1 $921,250 - $1.44 Million
-55,000 Reduced 44.0%
70,000 $1.74 Million
Q4 2023

Feb 14, 2024
BUY
$13.29 - $22.2 $1.35 Million - $2.25 Million
101,500 Added 431.91%
125,000 $2.26 Million
Q3 2023

Nov 14, 2023
BUY
$19.9 - $26.25 $467,649 - $616,875
23,500 New
23,500 $472,000

Others Institutions Holding BCYC

# of Institutions
111
Shares Held
40.8M
Call Options Held
39.6K
Put Options Held
24.6K
View Full List

About BICYCLE THERAPEUTICS plc

BCYC Quotes by TradingView
  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $415M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email